Test Price
2,800 AED✅ Home Collection Available
ABCB6 Gene Dyschromatosis Universalis Hereditaria Type 3 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين ABCB6 لاضطراب خلل التصبغ الشامل الوراثي من النوع الثالث في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited NGS Processing.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation provided by a DHA-licensed genetic specialist.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
ملخص تنفيذي
يوفر هذا التحليل الجيني المتقدم تقنية تسلسل الجيل التالي (NGS) للكشف الدقيق عن الطفرات في جين ABCB6 المرتبط بخلل التصبغ الشامل الوراثي من النوع الثالث. يعتمد الفحص ضمن إطار تشريعي كامل وفقًا للمرسوم بقانون اتحادي رقم 41 لسنة 2024 وقانون البيانات الصحية (PDPL) بدعم استشاري من أطباء هيئة الصحة بدبي. يتم تنفيذ الخدمة بضمان جودة عالمي (ISO 9001:2015) مع سحب منزلي معتمد، ونتائج خالية من الأخطاء، وإرشادات سريرية متكاملة.
Overview
The ABCB6 Gene Dyschromatosis Universalis Hereditaria Type 3 Genetic Test is a definitive molecular diagnostic that sequences the entire coding region of the ABCB6 gene using Next‑Generation Sequencing. Designed for individuals with suspected inherited pigmentation anomalies, this test confirms pathogenic variants responsible for Dyschromatosis Universalis Hereditaria (DUH) type 3, aiding accurate diagnosis, family screening, and personalized medical management.
| Parameter | Our Test (NGS‑Based DUH Type 3) | Closest Alternative (Single‑Gene Sanger Sequencing) |
|---|---|---|
| Diagnostic Precision | 99.9% sensitivity; detects SNVs, indels, CNVs across all exons | Limited to known hotspots; may miss deep intronic or large rearrangements |
| Methodology | Whole‑gene NGS with bioinformatic variant interpretation | Targeted PCR + capillary sequencing |
| Turnaround Time | 3 – 4 weeks (DHA‑compliant reporting) | 6 – 8 weeks |
Physician Insight & Safety Protocol
"As a DHA‑licensed dermatologist, I understand the anxiety that comes with progressive pigmentation changes. The ABCB6 NGS test provides a clear genetic answer, but it must always be correlated with clinical examination and detailed personal and family history. A positive result confirms predisposition to Dyschromatosis Universalis Hereditaria type 3, yet expression and severity can vary significantly. Please discuss any concerns with your treating physician; we are here to support you throughout this diagnostic journey."
— Dr. PRABHAKAR REDDY (DHA License: 61713011)
Medication Warning
Do not discontinue prescribed medication without consulting your doctor. Genetic test results do not replace ongoing clinical management.
Safety & Exclusion Criteria
- Exclusion Criteria: Patients who are unable to provide informed consent, those who have received a blood transfusion in the last 90 days, or individuals with active systemic infection requiring hospitalization.
- Emergency Red Flags: If you experience sudden, extensive hyper‑ or hypopigmentation accompanied by abdominal pain, mental status changes, or unexplained blistering, seek immediate emergency care. These may indicate a severe metabolic or porphyria‑like crisis unrelated to the test result.
Patient FAQ & Clinical Guidance
1. What does the ABCB6 gene do and why is it tested?
The ABCB6 gene encodes a mitochondrial transporter essential for heme synthesis and melanosome function; mutations disrupt normal pigmentation.
This examines the entire gene to identify disease‑causing variants in individuals with clinical features of Dyschromatosis Universalis Hereditaria type 3. Even if you are asymptomatic, a positive result informs family risk and guides prophylactic dermatological monitoring.
س: ما دور جين ABCB6 ولماذا يتم تحليله؟
ج: يشفر جين ABCB6 ناقلاً متقدرياً أساسياً لتخليق الهيم وتكوين الميلانوسومات، والطفرات فيه تؤدي إلى اضطراب التصبغ الوراثي.
2. Why is Next Generation Sequencing (NGS) used instead of older methods?
NGS reads all coding exons simultaneously, capturing point mutations, small deletions, and copy number variants with 99.9% accuracy missed by Sanger sequencing.
This comprehensive approach eliminates the need for sequential single‑exon testing, dramatically reducing diagnostic delay and the possibility of false‑negative results. It also adheres to the latest UAE genetic testing regulations that mandate the most sensitive technology available.
س: لماذا تُستخدم تقنية تسلسل الجيل التالي (NGS) بدلاً من الطرق القديمة؟
ج: يقرأ التسلسل من الجيل التالي جميع الإكسونات المشفرة دفعة واحدة، ويكتشف الطفرات النقطية والحذف الصغير واختلافات عدد النسخ بدقة 99.9% تفوق تسلسل سانجر.
3. How long does it take to receive the results?
Results are typically delivered within 3 to 4 weeks from sample receipt, fully compliant with DHA timeframe standards for genetic diagnoses.
During this period, your sample undergoes DNA extraction, library preparation, NGS, and rigorous bioinformatic analysis followed by a clinical geneticist review. You will be notified by WhatsApp as soon as the report is ready, and a complimentary tele‑consultation can be scheduled.
س: كم من الوقت يستغرق الحصول على النتائج؟
ج: تُسلم النتائج عادةً في غضون 3 إلى 4 أسابيع من استلام العينة، وفقاً للمعايير الزمنية المعتمدة من هيئة الصحة بدبي للتشخيصات الجينية.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians